Nuveen Asset Management LLC Reduces Stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Nuveen Asset Management LLC lowered its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 1.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,667,690 shares of the pharmacy operator’s stock after selling 25,944 shares during the period. Nuveen Asset Management LLC owned approximately 0.19% of Walgreens Boots Alliance worth $15,560,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently bought and sold shares of the company. NorthRock Partners LLC lifted its holdings in Walgreens Boots Alliance by 180.3% in the fourth quarter. NorthRock Partners LLC now owns 30,410 shares of the pharmacy operator’s stock valued at $284,000 after acquiring an additional 19,559 shares during the period. Occudo Quantitative Strategies LP acquired a new position in Walgreens Boots Alliance in the fourth quarter valued at approximately $242,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Walgreens Boots Alliance by 26.7% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 274,773 shares of the pharmacy operator’s stock valued at $2,564,000 after acquiring an additional 57,951 shares during the period. Moore Capital Management LP acquired a new position in Walgreens Boots Alliance in the fourth quarter valued at approximately $1,315,000. Finally, Integral Health Asset Management LLC acquired a new position in Walgreens Boots Alliance in the fourth quarter valued at approximately $4,665,000. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Analyst Upgrades and Downgrades

WBA has been the subject of a number of analyst reports. Truist Financial decreased their price target on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a report on Friday, January 31st. Deutsche Bank Aktiengesellschaft downgraded Walgreens Boots Alliance from a “hold” rating to a “sell” rating and decreased their price target for the company from $11.00 to $9.00 in a report on Friday, February 28th. Wolfe Research raised Walgreens Boots Alliance to a “hold” rating in a report on Monday, February 24th. Finally, Wall Street Zen assumed coverage on Walgreens Boots Alliance in a research note on Wednesday, May 21st. They set a “hold” rating for the company. Four research analysts have rated the stock with a sell rating, seven have given a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $10.59.

Walgreens Boots Alliance Stock Down 0.6%

NASDAQ WBA opened at $11.17 on Monday. The business has a fifty day moving average price of $11.02 and a 200 day moving average price of $10.43. Walgreens Boots Alliance, Inc. has a one year low of $8.08 and a one year high of $16.34. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. The company has a market cap of $9.66 billion, a P/E ratio of -1.09, a P/E/G ratio of 1.31 and a beta of 0.77.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Tuesday, April 8th. The pharmacy operator reported $0.63 EPS for the quarter, beating the consensus estimate of $0.53 by $0.10. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The firm had revenue of $38.59 billion during the quarter, compared to the consensus estimate of $37.90 billion. During the same period in the prior year, the company earned $1.20 EPS. The firm’s revenue was up 4.1% compared to the same quarter last year. Research analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

Insider Buying and Selling at Walgreens Boots Alliance

In related news, Chairman Stefano Pessina bought 832,258 shares of the company’s stock in a transaction on Sunday, April 27th. The stock was bought at an average cost of $11.01 per share, for a total transaction of $9,163,160.58. Following the acquisition, the chairman now directly owns 145,621,079 shares in the company, valued at $1,603,288,079.79. This represents a 0.57% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 17.50% of the stock is owned by company insiders.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.